Massimo Colombo
#171,815
Most Influential Person Now
Researcher
Massimo Colombo's AcademicInfluence.com Rankings
Massimo Colombocomputer-science Degrees
Computer Science
#10545
World Rank
#11081
Historical Rank
Machine Learning
#4810
World Rank
#4865
Historical Rank
Artificial Intelligence
#5182
World Rank
#5251
Historical Rank
Database
#7537
World Rank
#7816
Historical Rank
Download Badge
Computer Science
Massimo Colombo's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Massimo Colombo Influential?
(Suggest an Edit or Addition)Massimo Colombo's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. (2001) (3999)
- EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012) (3188)
- EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012) (2654)
- A proposed system for the nomenclature of hepatitis C viral genotypes (1994) (1100)
- Hepatocellular carcinoma in Italian patients with cirrhosis. (1991) (827)
- Statements from the Taormina expert meeting on occult hepatitis B virus infection. (2008) (784)
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study (2015) (706)
- PREVALENCE OF ANTIBODIES TO HEPATITIS C VIRUS IN ITALIAN PATIENTS WITH HEPATOCELLULAR CARCINOMA (1989) (673)
- Sustained virological response to interferon‐α is associated with improved outcome in HCV‐related cirrhosis: A retrospective study (2007) (625)
- Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance. (2004) (604)
- The natural history of compensated cirrhosis due to hepatitis C virus: A 17‐year cohort study of 214 patients (2006) (566)
- Field‐practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy (2011) (351)
- Prevention of hepatocellular carcinoma recurrence with alpha‐interferon after liver resection in HCV cirrhosis (2006) (347)
- Special article Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference (2001) (268)
- The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. (2009) (266)
- A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. (2009) (261)
- Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy. (2009) (258)
- Long‐Term suppression of hepatitis B e antigen‐negative chronic hepatitis B by 24‐month interferon therapy (2003) (230)
- Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a. (1995) (219)
- Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety study. (2013) (215)
- Prognostic gene expression signature for patients with hepatitis C-related early-stage cirrhosis. (2013) (185)
- Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C (2006) (184)
- Ulcerated hemangiomas: clinical characteristics and response to therapy. (2001) (181)
- Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. (2013) (172)
- Advancing the global public health agenda for NAFLD: a consensus statement (2021) (167)
- Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition. (2016) (150)
- Influence of different hepatitis C virus genotypes on the course of asymptomatic hepatitis C virus infection. (1996) (140)
- Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma (2018) (131)
- Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution. (2016) (114)
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study (2014) (111)
- Predictors of survival in patients with advanced hepatocellular carcinoma who permanently discontinued sorafenib (2015) (107)
- Treatment of hepatocellular carcinoma: beyond international guidelines (2015) (107)
- Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. (2013) (104)
- Management of hepatitis C virus genotype 4: recommendations of an international expert panel. (2011) (104)
- Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C. (2011) (102)
- Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound (2013) (98)
- Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial. (2004) (97)
- Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. (1983) (96)
- β‐blockade prevents recurrent gastrointestinal bleeding in well‐compensated patients with alcoholic cirrhosis: A multicenter randomized controlled trial (1989) (93)
- Asymptomatic liver disease in haemophiliacs. (1975) (92)
- Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action. (1998) (91)
- High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors (1999) (90)
- Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. (1996) (88)
- Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action (1998) (86)
- Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma. (2016) (82)
- Cost‐effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma (2013) (82)
- Intrahepatic chemotherapy for unresectable hepatocellular carcinoma (1988) (81)
- Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma (2011) (81)
- Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: The importance of tumor cell differentiation (2010) (80)
- Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma. (1999) (78)
- Nonpercutaneous therapies of hepatocellular carcinoma. (2001) (77)
- Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. (2003) (77)
- Hepatitis C virus and hepatocellular carcinoma. (1997) (76)
- Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study (2017) (75)
- Etiology, natural history and treatment of hepatocellular carcinoma. (2003) (74)
- Hepatocellular carcinoma in hemophilia (1991) (73)
- Screening for cancer in viral hepatitis. (2001) (72)
- Oral contraceptives and the risk of focal nodular hyperplasia of the liver: a case-control study. (2002) (70)
- A meta‐analysis of single HCV‐untreated arm of studies evaluating outcomes after curative treatments of HCV‐related hepatocellular carcinoma (2017) (68)
- Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma (2018) (65)
- A genomic and clinical prognostic index for hepatitis C-related early-stage cirrhosis that predicts clinical deterioration (2014) (64)
- Monoclonal antibody Ki-67 in the study of the proliferative activity of bladder carcinoma. (1992) (64)
- The epidemiology of hepatitis delta infection in Italy over the last 18 years. (1992) (62)
- Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma. (2014) (62)
- Liver precancerous lesions and hepatocellular carcinoma: the histology report. (2011) (61)
- Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy (2015) (57)
- The clinical and pathogenetic significance of estrogen receptor‐β expression in chronic liver diseases and liver carcinoma (2003) (57)
- Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma (2007) (52)
- PNPLA3 I148M Polymorphism, Clinical Presentation, and Survival in Patients with Hepatocellular Carcinoma (2013) (50)
- Screening and diagnosis of hepatocellular carcinoma (2009) (49)
- Distribution of basement membrane components in human hepatocellular carcinoma (1989) (45)
- Predictors of hepatocellular carcinoma in HCV cirrhotic patients treated with direct acting antivirals. (2019) (45)
- Chromogranin A levels in chronic liver disease and hepatocellular carcinoma. (2009) (45)
- Multidisciplinary strategies to improve treatment outcomes in hepatocellular carcinoma: a European perspective (2013) (40)
- Treatment of hepatocellular carcinoma: beyond international guidelines (2016) (40)
- 49 PEGINTRON MAINTENANCE THERAPY IN CIRRHOTIC (METAVIR F4) HCV PATIENTS, WHO FAILED TO RESPOND TO INTERFERON/RIBAVIRN (IR) THERAPY: FINAL RESULTS OF THE EPIC3 CIRRHOSIS MAINTENANCE TRIAL (2009) (39)
- Hepatocellular carcinoma in cirrhotics. (1993) (39)
- Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. (2005) (39)
- HBV infection and hepatocellular carcinoma. (2013) (38)
- Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop. (2011) (36)
- Segmental transcatheter arterial chemoembolization treatment in patients with cirrhosis and inoperable hepatocellular carcinomas. (2002) (34)
- The role of hepatitis C virus in hepatocellular carcinoma. (1998) (34)
- Transarterial chemoembolization with drug‐eluting beads is effective for the maintenance of the Milan‐in status in patients with a small hepatocellular carcinoma (2015) (34)
- Impact of HBV therapy on the incidence of hepatocellular carcinoma (2014) (33)
- Phase III randomized study of second line ADI-peg 20 (A) plus best supportive care versus placebo (P) plus best supportive care in patients (pts) with advanced hepatocellular carcinoma (HCC). (2016) (33)
- Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women (2005) (32)
- Fibronectin patterns in hepatocellular carcinoma and its clinical significance (1985) (32)
- Early diagnosis of hepatocellular carcinoma in Italy. A summary of a consensus development conference held in Milan, 16 November 1990 by the Italian Association for the Study of the Liver (AISF). (1992) (31)
- Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside (2012) (31)
- Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial. (2019) (31)
- Natural history and clinical impact of cryoglobulins in chronic hepatitis C: 10-year prospective study of 343 patients. (2007) (29)
- Beta-blockade prevents recurrent gastrointestinal bleeding in well-compensated patients with alcoholic cirrhosis: a multicenter randomized controlled trial. (1989) (28)
- [Transvaginal echography in the study of urinary stress incontinence]. (1996) (27)
- Risk factors for focal nodular hyperplasia of the liver: an Italian case-control study (2002) (24)
- For the EASL Panel of Experts on hepatocellular carcinoma (2001) (23)
- Contrast-enhanced computed tomography and ultrasound-guided liver biopsy to diagnose dysplastic liver nodules in cirrhosis. (2013) (22)
- Prevention of hepatocellular carcinoma. (2005) (22)
- FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program. (2011) (21)
- Choriocarcinoma coexistent with intrauterine pregnancy: two additional cases and a review of the literature. (1997) (21)
- EASL Clinical Practice Guideline: Occupational liver diseases. (2019) (21)
- Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations (2016) (21)
- Estimates of the Incidence and Prevalence of Hepatocellular Carcinoma in Italy in 2002 and Projections for the Years 2007 and 2012 (2009) (21)
- Observations of hepatocellular carcinoma (HCC) management patterns from the global HCC bridge study: First characterization of the full study population. (2012) (20)
- A cell culture system for distinguishing hepatitis C viruses with and without liver cancer-related mutations in the viral core gene. (2015) (20)
- Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging (2015) (20)
- Randomized phase II trial of intravenous RO5137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168). (2014) (20)
- Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy (2021) (20)
- Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma (2019) (19)
- Hepatocellular carcinoma in Italy: report of a clinical trial with intravenous doxorubicin. (2008) (18)
- The epidemiology of hepatitis delta infection in Italy. Promoting Group. (1992) (18)
- Detection of abnormal intrauterine vascularization by color Doppler imaging: a possible additional aid for the follow up of patients with gestational trophoblastic tumors (1996) (18)
- Definition of Healthy Ranges for Alanine Aminotransferase Levels: A 2021 Update (2021) (17)
- The natural history of hepatocellular carcinoma in Western countries. (1998) (17)
- Recent progress and new trends in the treatment of hepatitis B (2002) (16)
- HBV-related HCC, clinical issues and therapy. (2011) (16)
- Hepatocellular Carcinoma Screening and Diagnosis (2014) (15)
- Surveillance for hepatocellular carcinoma: A standard of care, not a clinical option (2011) (15)
- Hepatocellular carcinoma in patients with HCV. (2000) (13)
- Vitamin D deficiency and liver cancer: More than just an epidemiological association? (2014) (13)
- Erratum: impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: Results of a European concerted action (Journal of Hepatology (1998) 29 (173-83)) (1998) (12)
- Viral hepatitis as a risk factor for the development of hepatocellular carcinoma (2020) (11)
- Determinants of esophageal varices bleeding in patients with advanced hepatocellular carcinoma treated with sorafenib (2016) (11)
- The strategic role of staging in the treatment of HCC (2004) (10)
- The dilemma for patients with chronic hepatitis C: treat now or warehouse? (2014) (10)
- The European approach to hepatocellular carcinoma. (2002) (10)
- Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease. (2021) (9)
- Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma (1991) (9)
- A prospective study of blood alpha‐fetoprotein messenger RNA as a predictor of hepatocellular carcinoma in patients with cirrhosis (2003) (9)
- HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study (2016) (8)
- Screening for Hepatocellular Carcinoma (1998) (8)
- Hepatitis C virus and hepatocellular carcinoma. (1999) (8)
- Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma (2021) (7)
- Controlling liver cancer mortality on a global scale: Still a long way to go. (2017) (7)
- Clinical features and outcomes of hepatocellular carcinoma in Caucasian cirrhotic patients on long‐term analogue therapy for hepatitis B (2018) (6)
- 295 Final Results of the EPIC3 Cirrhosis Maintenance Trial: Pegintron Maintenance Therapy in Cirrhotic (METAVIR F4) HCV Patients, Who Failed to Respond to Interferon/Ribavirn (IR) Therapy: (2009) (6)
- Treatment of hepatocellular carcinoma (1997) (6)
- Natural history of hepatocellular carcinoma (2005) (5)
- Systemic therapy for advanced cholangiocarcinoma: new options on the horizon (2020) (5)
- Case-control study of hepatitis B virus infection in chronic liver disease and hepatocellular carcinoma (1984) (5)
- EASL Clinical Practice Guidelines on the Management of Benign Liver Tumors (2020) (5)
- Sofosbuvir and risk of estimated glomerular filtration rate decline or end‐stage renal disease in patients with renal impairment (2022) (4)
- How I manage my patients with hepatocellular carcinoma (2011) (4)
- Current and future challenges in HCV: insights from an Italian experts panel (2018) (4)
- P.229 HCV-1 subtypes and response to pegylated interferon plus ribavirin therapy (2006) (4)
- Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C. (2016) (4)
- Does chemotherapy prevent HBV-related hepatocellular carcinoma? Cons. (2010) (4)
- Detection of preclinical hepatocellular carcinoma in patients with cirrhosis (1993) (3)
- Hepatitis C infection and hepatocellular carcinoma (2003) (3)
- Multikinase inhibitors to treat hepatocellular carcinoma failures to sorafenib—time has come for a better approach (2020) (3)
- The 67th Annual Meeting of the American Association for the Study of Liver Diseases: The Liver Meeting 2016. (2016) (3)
- [Use of the monoclonal antibody KI-67 in the study of the proliferative activity of urologic tumors. Preliminary data]. (1987) (3)
- HCV–Related Mixed Cryoglobulinemia: Data from Piter, a Nationwide Italian HCV Cohort Study (2016) (3)
- Multidisciplinary approach to hepatocellular carcinoma. Preface. (2010) (3)
- Tumors of the Liver and Biliary Tract (1992) (3)
- Predicitive value of serum α‐fetorprotein in cirrhosis (1994) (3)
- Decrease in suppressor/cytotoxic T-cells with histamine receptors in patients with chronic active hepatitis. (2008) (2)
- Hepatitis C virus and hepatocellular carcinoma. (1995) (2)
- Surveillance for hepatocellular carcinoma in patients with advanced liver fibrosis (2021) (2)
- Treatment of hepatocellular carcinoma. (2001) (2)
- High prevalence of antibody to hepatitis C virus in patients with hepatocellular carcinoma (HCC) (1989) (2)
- A Real‐World Observational Cohort of Patients with Hepatocellular Carcinoma: Design and Rationale for TARGET‐HCC (2020) (2)
- HCC BRIDGE study : BRIDGE to better outcomes in hepatocellular carcinoma (2009) (2)
- Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook (2022) (2)
- The long-term course of hepatitis C-related cirrhosis (2002) (2)
- Hepatocellular Carcinoma: Diagnosis and Prognosis (2019) (1)
- 49 – Benign Liver Tumors (2018) (1)
- The impact of surveillance on hepatocellular carcinoma. Detection and survival of 417 patients with compensated cirrhosis: a 12-year prospective cohort study (2002) (1)
- Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true? (2022) (1)
- Recist versus easl criteria for the evaluation of HCC response to sorafenib (2009) (1)
- Liver field during immunotherapy of hepatocellular carcinoma: some like it hot. (2021) (1)
- 719 OBSERVATIONS OF HEPATOCELLULAR CARCINOMA (HCC) MANAGEMENT PATTERNS FROM THE GLOBAL HCC BRIDGE STUDY: SECOND INTERIM ANALYSIS OF THE EUROPEAN (EU) COHORT (2012) (1)
- 699 OBSERVED PATTERNS OF SYSTEMIC THERAPY USE IN HEPATOCELLULAR CARCINOMA (HCC) PATIENTS FROM THE MULTINATIONAL HCC BRIDGE STUDY: RESULTS OF A SECOND INTERIM ANALYSIS (2012) (1)
- [Hepatocellular carcinoma]. (2016) (1)
- β Blockers in the Secondary Prevention of Gastrointestinal Haemorrhage in Well-Compensated Cirrhotics (2012) (1)
- Laser ablation in urology (1990) (1)
- Validation of Mesiah Score System in Patients with Hepatocellular Carcinoma (2016) (1)
- [Drugs, impotence and infertility]. (1991) (1)
- The exposome and liver disease - how environmental factors affect liver health. (2023) (1)
- Results of long term treatment of advanced prostatic cancer with the LHRH analogue buserelin. (1987) (1)
- The EASL International Liver Foundation: A growing pup with missions that are distinct yet integrated with those of its mother. (2019) (1)
- A therapeutic conundrum: Delaying ablation of small nonresectable early hepatocellular carcinoma to facilitate liver transplantation (2015) (1)
- 40. Hepatocellular Carcinoma (2010) (1)
- Efficacy and Safety of Elbasvir/Grazoprevir in Patients with Chronic Hepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study (2016) (1)
- 251 A sirna targeted against srf reduces hepatocellular carcinoma cell proliferation, showing its potential use in the growth inhibition of this type of tumour (2006) (1)
- Adjusting BCLC staging system to the evolving landscape of Hepatocellular Carcinoma. A look to the future. (2022) (1)
- Beta-blockers in the secondary prevention of gastrointestinal haemorrhage in well-compensated cirrhotics. A multicentre randomised controlled study. (1989) (0)
- Natural history of hepatocellular carcinoma. (2008) (0)
- Surveillance and prevention of hepatocellular carcinoma (2008) (0)
- The course of focal nodular hyperplasia (FNH) in 24 asymptomatic carriers (2000) (0)
- [Use of orgotein in the treatment of plastic penile induration]. (1988) (0)
- MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals (2017) (0)
- Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct-acting antivirals. (2023) (0)
- Clinico-Pathological Features of Hepatocellular Carcinoma (2005) (0)
- Matiral history of asymptomatic HBsAg carriers; A 13-year follow-up study (1991) (0)
- Entering a new era in the treatment of hepatitis C. (2014) (0)
- Validation of the ALBI grade as a substitute for the Child-Pugh class in the BCLC classification of hepatocellular carcinoma and of the additional value provided by the Neutrophil-to-Lymphocyte Ratio (2017) (0)
- 6501 ORAL Observations of Hepatocellular Carcinoma (HCC) Management Patterns From the Multinational HCC BRIDGE Study – First Overall Analysis of the European Cohort (2011) (0)
- HCC in Italy. Prognostic factors in a retrospective study of 238 cases (1989) (0)
- Contents Vol. 33, 2015 (2015) (0)
- Hcv Genotypes in Italian Patients With Chronic Hcv Infection: A Prospective Multicentre Study (1996) (0)
- Molecular Aspects of Hepatocellular Carcinoma (2018) (0)
- The maze of systemic therapy for hepatocellular carcinoma: did we find the compass? (2021) (0)
- [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy]. (1982) (0)
- SAT-454-Management of hepatocellular carcinoma in a real life multinational, longitudinal, observational study (TARGET-HCC) (2019) (0)
- Diagnosis and Stratification of Hepatocellular Carcinoma (2011) (0)
- Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235] (2013) (0)
- PNPLA3 I148M polymorphism, etiology, and clinical features of hepatocellular carcinoma (2011) (0)
- 480 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT (2011) (0)
- OUTCOMES OF PATIENTS INTERRUPTING GLECAPREVIR/PIBRENTASVIR TREATMENT: A CASE SERIES FROM CLINICAL TRIALS (2019) (0)
- Chapter 59 – Benign Liver Tumors (2012) (0)
- Screening (2007) (0)
- Effect of salmon calcitonin on human adherent monocytes after exposure to heat-shock (1993) (0)
- [Pseudo-trilocular urinary bladder due to symmetrical mega-diverticulosis]. (1968) (0)
- Sorafenib treatment of advanced hepatocellular carcinoma : a post-marketing study (2009) (0)
- Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCC (2022) (0)
- Hepatocellular carcinoma. (1992) (0)
- Rival Scoring Systems: Do they Offer more? (2011) (0)
- [Incidence of HBsAg in persons living with HBsAg carriers]. (1975) (0)
- Reply: (2012) (0)
- [Effect of ethanol and phenobarbital on liver UDPG-transferase and on serum bilirubin in patients with Gilbert's syndrome]. (1972) (0)
- Use of mepartricin in the treatment of benign prostatic hypertrophy. Open study of 39 patients (1988) (0)
- Cost-Effective Use of Interferon-α in Hepatitis C (1997) (0)
- Management of Hepatocellular Carcinoma (2013) (0)
- 12 Clinico-Pathological Features of Hepatocellular Carcinoma (0)
- Hepatitis C virus and hepatocellular carcinoma. (1999) (0)
- Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C. (2016) (0)
- A prospective study of alfafetoprotein (AFP) mRNA in peripheral blood of cirrhotics as a predictor of hepatocellular carcinoma (HCC) (2000) (0)
- A prospective study of lens culinaris agglutinin-reactive alpha-fetoprotein as a predictor of hepatocellular carcinoma in cirrhotics (2000) (0)
- FibroTest™ Is an Independent Predictor of Early and Sustained Virologic Response in Nonresponder Patients With Chronic Hepatitis C: Results From the EPIC 3 Study (2009) (0)
- Intrahepatic cholangiocellular carcinoma with radiologic enhancement pattern mimicking hepatocellular carcinoma (2020) (0)
- The long-term course of hepatitis C — Related cirrhosis (2001) (0)
- CMAR_A_330195 9379..9389 (2021) (0)
- 12 Clinico-Pathological Features of Hepatocellular Carcinoma (0)
- [Reliability of transrectal echography in the early diagnosis of prostatic carcinoma: our experience]. (1991) (0)
- Management of HCC : East meet West (West) (2007) (0)
- Goodbye from Milan (2009) (0)
- Radiofrequency (RF) ablation with cooled needle electrode of hepatocellular carcinoma in patients with compensated cirrhosis (2000) (0)
- Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines (2023) (0)
- [Emphysema of the respiratory bronchioles and its relation to alveolar emphysema from the current anatomo-pathologic view-point on the emphysematous disease]. (1968) (0)
- The course of chronic infection with hepatitis delta virus: A 20-year cohort study of 299 Italian patients (2008) (0)
- Treating paediatric hepatitis C in the era of direct‐acting antiviral agents (2021) (0)
- Bridging to liver transplantation patients with a hepatocellular carcinoma within Milan criteria: how worth is it? (2018) (0)
- 69 Local circulation of VEGF is involved in collateral vessels development in cirrhotic patients with portal hypertension (2006) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Massimo Colombo?
Massimo Colombo is affiliated with the following schools:
